Vaccine News and Research

Latest Vaccine News and Research

New UK funding will help tackle the world's most pressing health challenges

New UK funding will help achieve UN Sustainable Development Goals by boosting health security and improving health and wellbeing around the world.

21 Sep 2023

KFF Health News' 'What the Health?': Countdown to shutdown

Health and other federal programs are at risk of shutting down, at least temporarily, as Congress races toward the Oct. 1 start of the fiscal year without having passed any of its 12 annual appropriations bills.

21 Sep 2023

Manipulating mitochondrial electron flow enhances immune response, reduces tumor growth

Immunotherapy, which uses the body's own immune system to fight cancer, is an effective treatment option, yet many patients do not respond to it.

21 Sep 2023

Study offers new insight into immune cells critical to successful vaccination against SARS-CoV-2

A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.

21 Sep 2023

New trial of a preventive HIV vaccine candidate begins in the United States and South Africa

A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa.

20 Sep 2023

American Thoracic Society partners with five new health systems to improve vaccination rates

As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to improve vaccination rates.

20 Sep 2023

Early treatment with convalescent plasma may reduce risk of long COVID

Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing post-COVID conditions - commonly known as long COVID - if they receive early treatment with plasma from convalescent (recovered) COVID patients that contain antibodies against SARS-CoV-2, the virus that causes COVID-19.

20 Sep 2023

Vaccine impact: BNT162b2 and pediatric COVID-19 ambulatory visits in kids under 5

The association between BNT162b2 vaccine and (COVID-19)-related ambulatory visits.

20 Sep 2023

Innovations in baculovirus–insect cell expression systems

The baculovirus–insect cell expression system—insect cells used in conjunction with the baculovirus expression vector system (BEVS)— remains a crucial technology for manufacturing large and complex proteins. This eukaryotic expression system offers inherent safety, ease of scale-up, flexible product design, and versatility for a broad range of proteins.

From Sino Biological Inc. 20 Sep 2023

Game-changing point-of-care assay could revolutionize Mpox detection worldwide

Researchers developed a point-of-care assay for the rapid detection of mpox virus.

20 Sep 2023

Age and underlying conditions increase risk of critical outcomes for hospitalized COVID-19 patients

Whether vaccinated or not, having at least four disease risk factors put adults hospitalized due to COVID-19 at higher risk for critical outcomes, according to a 10-state study from the Centers for Disease Control and Prevention's (CDC's) VISION Network.

19 Sep 2023

Study finds risk factors linked to lower flu vaccine uptake in people with kidney disease

Among adults with chronic kidney disease (CKD) enrolled in the Chronic Renal Insufficiency Cohort (CRIC), young age, Black race, and low levels of education and income were associated with lower likelihood of getting an annual flu shot.

19 Sep 2023

Study assesses duration of protection offered by smallpox infection and possible cross-reaction with Mpox virus

More than 43 years ago, many Chinese residents were vaccinated with the vaccinia virus Tiantan strain (VTT) to protect them from smallpox infection.

19 Sep 2023

Inactivated poliovirus vaccine elicits persistent immunity for up to 10 years

The neutralizing antibodies persistence of the Sabin strain-derived inactivated poliovirus vaccine.

19 Sep 2023

Does a high-dose influenza vaccine reduce cardiovascular disease risk?

Whether a high-dose influenza vaccine is associated with a benefit in reducing CP events.

19 Sep 2023

Adaptive platform trial shows promise for finding new glioblastoma therapies

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.

19 Sep 2023

Is Facebook's fight against vaccine misinformation failing?

Researchers found that Facebook's policies on removing COVID-19 vaccine misinformation are partially ineffective, as user engagement with anti-vaccine content did not decrease. The study suggests that the platform's system architecture allows users to bypass misinformation-curbing policies, making it challenging to combat the spread effectively.

18 Sep 2023

How did exposure to news on COVID-19 through social platforms impact psychological health and behavior?

The relationship between news on the COVID-19 pandemic through social media, feelings of fear and anxiety, and behavior.

18 Sep 2023

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

The bivalent COVID-19 vaccine developed by GSK and Sanofi shows promising results with a 64.7% overall effectiveness against symptomatic COVID-19, according to a phase 3 trial. The vaccine performs especially well as a booster, achieving 75.9% efficacy in non-naïve subjects.

17 Sep 2023

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

The study explores the efficacy of three-dose monovalent or bivalent vaccinations in neutralizing newly emerged SARS-CoV-2 variants BA.2.86 and FLip. While BA.2.86 showed lower immune evasion abilities compared to recent XBB variants, it was less effectively neutralized by the monoclonal antibody S309, raising questions about vaccine efficacy against evolving strains.

17 Sep 2023

Previous
1
...
57
58
59
60
61
62
63
...
1124
Next

Vaccine News and Research

Latest Vaccine News and Research

New UK funding will help tackle the world's most pressing health challenges

KFF Health News' 'What the Health?': Countdown to shutdown

Manipulating mitochondrial electron flow enhances immune response, reduces tumor growth

Study offers new insight into immune cells critical to successful vaccination against SARS-CoV-2

New trial of a preventive HIV vaccine candidate begins in the United States and South Africa

American Thoracic Society partners with five new health systems to improve vaccination rates

Early treatment with convalescent plasma may reduce risk of long COVID

Vaccine impact: BNT162b2 and pediatric COVID-19 ambulatory visits in kids under 5

Innovations in baculovirus–insect cell expression systems

Game-changing point-of-care assay could revolutionize Mpox detection worldwide

Age and underlying conditions increase risk of critical outcomes for hospitalized COVID-19 patients

Study finds risk factors linked to lower flu vaccine uptake in people with kidney disease

Study assesses duration of protection offered by smallpox infection and possible cross-reaction with Mpox virus

Inactivated poliovirus vaccine elicits persistent immunity for up to 10 years

Does a high-dose influenza vaccine reduce cardiovascular disease risk?

Adaptive platform trial shows promise for finding new glioblastoma therapies

Is Facebook's fight against vaccine misinformation failing?

How did exposure to news on COVID-19 through social platforms impact psychological health and behavior?

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in